TAMIR BIOTECHNOLOGY, INC.: key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2012)
- $500.0K
- Net Income/Loss (FY2012)
- $2.0M
- Total Assets (FY2012)
- $79.9K
- Total Equity (FY2012)
- -$6.1M
- Cash Flows from Operating Activities (FY2012)
- -$345.3K
Source: TAMIR BIOTECHNOLOGY, INC. 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
